scorecardresearch
Add as a preferred source on Google
Friday, December 19, 2025
TopicCovid vaccine

Topic: Covid vaccine

Modi govt mustn’t hesitate to make Covid vaccine free for Indians. It only costs Rs 80,000 cr

Serum Institute CEO Adar Poonawalla asked if the government is willing to pay Rs 80,000 crore to vaccinate all Indians. The money isn’t such a big deal.

Antibiotic Teicoplanin 10 times more effective than Covid drugs like HCQ, says IIT Delhi study

Teicoplanin is an FDA-approved glycopeptide antibiotic, which is regularly used for treating Gram-positive bacterial infections with low toxicity profile in humans.

Will govt have Rs 80,000 crore to buy, distribute Covid vaccine, asks Serum Institute CEO

Adar Poonawalla said there was a need to plan and guide vaccine manufacturers on procurement and distribution methods.

China’s vaccines produced antibodies that lasted 6 months, says country’s top scientist

The high levels of antibodies show that the shots can provide immunity against the virus for a longer period of time, chief scientist Zeng Guang said.

Trump threatens to veto FDA if it tries to slow down launch of Covid vaccine

FDA officials have indicated they would hold a Covid vaccine to a higher standard than other medications that typically receive emergency waivers from the agency.

Bharat Biotech partners with Washington University for Covid intranasal vaccine

While the Phase 1 trial will take place in St Louis University's Vaccine and Treatment Evaluation Unit, Bharat Biotech, will pursue further stages of clinical trials in India.

Mumbai’s KEM Hospital starts trials of Oxford Covid vaccine

The hospital Tuesday got the approval of the Maharashtra ethics committee for conducting the Phase 2 & 3 trials of the vaccine, Covishield, and has started screening volunteers.

More than half of France in red zone, hospitals in Jakarta lack capacity & other Covid news

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

China split on vaccine doses, South African teachers demand pay raise & other Covid news

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

Vaccine likely in India by first half of 2021 if ‘good results by year-end’, top scientist says

Any vaccine currently in phase three trials has a 50% chance of success, says scientist Gagandeep Kang who is a member of WHO’s Global Advisory Committee on Vaccine Safety.

On Camera

Why SIR is an exclusionary exercise for Persons with Disabilities

In the ongoing SIR 2.0 exercise, nearly half of the 90 lakh registered PwD voters in India were affected, showed an RTI application.

Antitrust watchdog Competition Commission to probe IndiGo flight disruptions

While the commission didn’t mention provisions under which IndiGo's market domination would be examined, Competition Act 2002 prohibits abuse of dominant position by any enterprise.

Israel has ‘realised who its real friend is’, eyes defence expansion in India amid arms curbs by others

It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.

India’s top airline just handed sarkar the keys. That’s IndiGo’s real ‘crime’

Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.